EUVIMEDEUVIMED entdecken
Crossref

PET-CT SUVmax and Endobronchial Ultrasound Features for Prediction of Malignancy: A Prospective Study

Nuno Faria, Catarina Lacerda, Jennifer Lopes, Cristina Viana, Maria Sucena

Clinical Lung Cancer · 2023

DOI: 10.1016/j.cllc.2023.08.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lung Cancer, 2023. Verfasst von Nuno Faria und 4 weiteren Autor:innen. Beteiligte Einrichtung: Bronchology and Pleural Pathology Unit, Department of Pulmonology, Centro Hospitalar Universitário de Santo António, Portugal. Electronic address: nu…. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Accurate and early staging of lung cancer has a critical impact on its prognosis. EBUS-TBNA is often the procedure of choice for mediastinal staging. Comprehension of the likelihood of malignancy of each lymph node (LN) can assist puncture decision-making during EBUS and offer insight of the procedure expected diagnostic yield. METHODS: Prospective analysis of mediastinal LN of patients undergoing EBUS-TBNA from April 2021 to May 2022. The relationship between PET-CT SUVmax levels, EBUS features, and malignancy on LN was investigated. For statistical analysis, patients were assigned to 3 groups: suspected malignancy (diagnosis and/or staging), confirmed malignancy (staging) or suspected benign disease. RESULTS: A total of 363 LN from 132 patients (71% male, mean 62 years old) were analyzed. Among those with suspected benign disease, no LN puncture resulted in a diagnosis of malignancy. PET-CT SUVmax and short axis size were independent factors for malignancy in LN of patients who underwent EBUS for suspected (p < .001 and p = .047, respectively) or confirmed malignancy (p < .001 and p < .001, respectively). All malignant LN presented SUVmax≥1.85 (≥2.85 for staging EBUS cases) and/or short axis size ≥4.28mm. Vascularized LN were more often malignant in either those with suspected (p = .087) or confirmed (p = .095) malignancy, although not statistically significant. LN that were simultaneously vascularized and lacked central hilar structure were also more commonly malignant (p = .013). CONCLUSION: LN that has higher SUVmax and are larger should be prioritized for puncture, followed by those vascularized and lacking central hilar structure. In staging EBUS cases, a systematic sampling (N3-N2-N1) is required and must precede any malignancy yield rationale.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHumansMaleMiddle AgedFemalePositron Emission Tomography Computed TomographyProspective StudiesBronchoscopyNeoplasm StagingMediastinumLymph NodesRetrospective Studies

Stichwörter der Autor:innen

Bronchoscopy, EBUS-TBNALung cancer, PET-CTLymph nodeMediastinal stagingSUV(max)

Autor:innen und Institutionen

  • Bronchology and Pleural Pathology Unit, Department of Pulmonology, Centro Hospitalar Universitário de Santo António, Portugal. Electronic address: nunomachadofaria@gmail.com.
  • Bronchology and Pleural Pathology Unit, Department of Pulmonology, Centro Hospitalar Universitário de Santo António, Portugal.

Zitieren

APA

Faria, N., Lacerda, C., Lopes, J., Viana, C., & Sucena, M. (2023). PET-CT SUVmax and Endobronchial Ultrasound Features for Prediction of Malignancy: A Prospective Study. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2023.08.005

Vancouver

Faria N, Lacerda C, Lopes J, Viana C, Sucena M. PET-CT SUVmax and Endobronchial Ultrasound Features for Prediction of Malignancy: A Prospective Study. Clinical Lung Cancer. 2023. doi:10.1016/j.cllc.2023.08.005

BibTeX
@article{Faria2023,
  author = {Faria, Nuno and Lacerda, Catarina and Lopes, Jennifer and Viana, Cristina and Sucena, Maria},
  title = {PET-CT SUVmax and Endobronchial Ultrasound Features for Prediction of Malignancy: A Prospective Study},
  journal = {Clinical Lung Cancer},
  year = {2023},
  doi = {10.1016/j.cllc.2023.08.005}
}
Kostenlos starten →